Impaired Nrf2 activity through NF-κβ activation has been demonstrated in other chronic inflammatory disorders such as chronic granulomatous disease [16], suggesting that impaired Nrf2 activity in CKD appears to be at least, in part, due to the accompanying systemic inflammation. The gene discussed is NFE2L2; the disease is chronic granulomatous disease.